Long‐term follow‐up confirms the favourable prognostic impact of high numbers of tumour infiltrating <scp>CD3</scp> T‐cells in follicular lymphoma patients treated by rituximab‐maintenance regimen-Reference-Cited by-同舟云学术

Long‐term follow‐up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T‐cells in follicular lymphoma patients treated by rituximab‐maintenance regimen

Published:2023-05-22 Issue:3 Volume:202 Page:686-689
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Laurent Camille¹^ORCID,Flores Maria²,Chartier Loïc²,Huet Sarah³,Bolen Christopher R.⁴,Venstrom Jeffrey M.⁴,Chassagne‐Clément Catherine⁵,Dartigues‐Cuilléres Peggy⁶,Charlotte Fréderic⁷,Tesson Bruno²,Salles Gilles⁸,Morschhauser Franck⁹,Xerri Luc¹⁰

Affiliation:

1. Institut Universitaire Cancer‐Oncopole CHU Toulouse, INSERM U1037 Toulouse France

2. LYSARC Pierre Bénite France

3. Hospices Civils De Lyon Pierre Bénite France

4. Genentech Inc. South San Francisco California USA

5. Centre Léon Bérard Lyon France

6. Institut Gustave Roussy Villejuif France

7. Centre Hospitalier Pitié‐Salpêtriére Paris France

8. Memorial Sloan Kettering Cancer Center New York New York USA

9. Hôpital Claude Huriez Lille France

10. Institut Paoli‐Calmettes, CRCM and Aix‐Marseille University Marseille France

Publisher